Skip to content

Study on Oral administration of Amruthadi ksheerakashayapana and Panchavalkala taila yonipichu in Genitourinary Syndrome of Menopause

Effect of Amruthadi Ksheerakashayapana And Panchavalkala taila Yonipichu In Genitourinary Syndrome of Menopause.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052433
Enrollment
24
Registered
2023-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N958- Other specified menopausal and perimenopausal disorders

Interventions

None listed

Sponsors

Safeera K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females within the age group of 40 to 60 who attained menopause presenting with symptoms of genitourinary syndrome of menopause will be taken for the study. Any 3 of the following symptoms are considered for inclusion. 1. Vaginal dryness 2. Burning sensation in vagina 3. Pain during sexual intercourse 4. Dysuria 5. Increased need to urinate 6. Urinary incontinence Patients willing and competent to give consent

Exclusion criteria

Exclusion criteria: 1. Women with known cases of uncontrolled diabetes mellitus and hypertension 2. Patients with known systemic illness-renal disorders ,liver dysfunction 3. Infections of genital tract 4. Known cases of genital malignancies 5. Receiving hormone therapy

Design outcomes

Primary

MeasureTime frame
CHANGE IN UROGENITAL SUBSCALE OF MENOPAUSE RATING SCALE, MATURATION INDEX VAGINAL pHTimepoint: Assessment of subjects will be done on before treatment, on 90th day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR Rajitha R Warriar

Kerala University of Health science

drrajithawarriar@gmail.com9947144562

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026